Canopy Growth Corporation
CGCNASDAQHealthcare● Active
$1.03
$-0.01(-0.49%)
Market Cap$436481900
P/E Ratio—
52W High$2.38
52W Low$0.844
Canopy Growth Corporation (CGC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CGC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 29, 2026EPS Actual
-$0.94
Est. -$0.06 · -1466.7%
Revenue
—
Est. $0.05B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 29, 2026
After Market Close
▼ Miss EPS
CGC reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.19
Rev. $0.35B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.19
Rev. Est.$0.35B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 15, 2026 | -$0.06 | — | — | — | $0.07B | — |
| ▼ Q2 FY2026 | May 29, 2026 | -$0.06 | -$0.94 | -1466.7% | — | $0.05B | — |
| ▼ Q1 FY2026 | Feb 6, 2026 | -$0.03 | -$0.10 | -233.3% | $0.05B | $0.05B | +5.2% |
| ▲ Q4 FY2025 | Nov 7, 2025 | -$0.11 | -$0.01 | +90.9% | $0.07B | $0.07B | -6.1% |
| ▲ Q3 FY2025 | Aug 8, 2025 | -$0.15 | -$0.14 | +6.7% | $0.05B | $0.07B | -24.2% |
| ▼ Q2 FY2025 | May 30, 2025 | -$0.10 | -$0.94 | -840.0% | $0.04B | $0.07B | -33.6% |
| ▼ Q1 FY2025 | Feb 7, 2025 | -$0.38 | -$0.76 | -100.0% | $0.05B | $0.07B | -27.9% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -$0.38 | -$0.95 | -150.0% | $0.05B | $0.05B | -1.4% |
Q2 FY2026
Jun 15, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 29, 2026Miss
EPS Actual
-$0.94
EPS Est.
-$0.06
EPS Surpr.
-1466.7%
Revenue
—
Q1 FY2026
Feb 6, 2026Miss
EPS Actual
-$0.10
EPS Est.
-$0.03
EPS Surpr.
-233.3%
Revenue
$0.05B
Q4 FY2025
Nov 7, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.11
EPS Surpr.
+90.9%
Revenue
$0.07B
Q3 FY2025
Aug 8, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$0.15
EPS Surpr.
+6.7%
Revenue
$0.05B
Q2 FY2025
May 30, 2025Miss
EPS Actual
-$0.94
EPS Est.
-$0.10
EPS Surpr.
-840.0%
Revenue
$0.04B
Q1 FY2025
Feb 7, 2025Miss
EPS Actual
-$0.76
EPS Est.
-$0.38
EPS Surpr.
-100.0%
Revenue
$0.05B
Q4 FY2024
Nov 8, 2024Miss
EPS Actual
-$0.95
EPS Est.
-$0.38
EPS Surpr.
-150.0%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2027 | $-0.02 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.02 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.05 | $-0.04 | $-0.04 | 1 |
| Q4 FY2026 | $-0.05 | $-0.05 | $-0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 29, 2026 | -1466.7% | $1.12 | $1.09 | -2.68% |
| ▼ Q1 FY2026 | Feb 6, 2026 | -233.3% | $1.08 | $1.10 | +1.85% |
| ▲ Q4 FY2025 | Nov 7, 2025 | +90.9% | $1.09 | $1.17 | +7.34% |
| ▲ Q3 FY2025 | Aug 8, 2025 | +6.7% | $1.05 | $1.25 | +19.05% |
| ▼ Q2 FY2025 | May 30, 2025 | -840.0% | $1.71 | $1.32 | -22.81% |
| ▼ Q1 FY2025 | Feb 7, 2025 | -100.0% | $2.78 | $2.02 | -27.34% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -150.0% | $4.55 | $4.24 | -6.81% |
| ▼ Q3 FY2024 | Aug 9, 2024 | -19.4% | $6.92 | $6.37 | -7.95% |
Q2 FY2026-2.68%
Report Date
May 29, 2026
EPS Beat/Miss
-1466.7%
Price Before
$1.12
Price After
$1.09
Q1 FY2026+1.85%
Report Date
Feb 6, 2026
EPS Beat/Miss
-233.3%
Price Before
$1.08
Price After
$1.10
Q4 FY2025+7.34%
Report Date
Nov 7, 2025
EPS Beat/Miss
+90.9%
Price Before
$1.09
Price After
$1.17
Q3 FY2025+19.05%
Report Date
Aug 8, 2025
EPS Beat/Miss
+6.7%
Price Before
$1.05
Price After
$1.25
Q2 FY2025-22.81%
Report Date
May 30, 2025
EPS Beat/Miss
-840.0%
Price Before
$1.71
Price After
$1.32
Q1 FY2025-27.34%
Report Date
Feb 7, 2025
EPS Beat/Miss
-100.0%
Price Before
$2.78
Price After
$2.02
Q4 FY2024-6.81%
Report Date
Nov 8, 2024
EPS Beat/Miss
-150.0%
Price Before
$4.55
Price After
$4.24
Q3 FY2024-7.95%
Report Date
Aug 9, 2024
EPS Beat/Miss
-19.4%
Price Before
$6.92
Price After
$6.37
Avg Beat Reaction+13.20%
Avg Miss Reaction-10.96%
Beat Rate2 / 8 quarters
Largest Move-27.34% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CGC ends December
Canopy Growth Corporation (CGC) most recently reported earnings on May 29, 2026 for Q2 FY2026, posting EPS of $-0.94 — missing the analyst consensus of $-0.06 by -1466.7%. The next CGC earnings date is expected around September 1, 2026.
Each quarter, investors track CGC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CGC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CGC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CGC earnings · 5 questionsCanopy Growth Corporation's next earnings report is expected around September 1, 2026. CGC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CGC historically reports after market close (AMC).
CGC earnings datewhen is CGC earningsCGC next earnings datewhen does CGC report earningsCGC earnings calendar
▸ Source: FMP · Canopy Growth Corporation SEC filings · US GAAP · Canopy Growth Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026